These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1754810)
1. Anti-dsDNA: choice of assay in relation to clinical value. Smeenk RJ; van den Brink HG; Brinkman K; Termaat RM; Berden JH; Swaak AJ Rheumatol Int; 1991; 11(3):101-7. PubMed ID: 1754810 [TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to DNA: a technical assessment. Smeenk R; Hylkema M Mol Biol Rep; 1992 Nov; 17(1):71-9. PubMed ID: 1287479 [TBL] [Abstract][Full Text] [Related]
3. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test. Werle E; Blazek M; Fiehn W Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405 [TBL] [Abstract][Full Text] [Related]
4. [Detection of dsDNA antibodies in diagnosis of systemic lupus erythematosus--comparative studies of diagnostic effectiveness of 3 ELISA methods with different antigens and a Crithidia luciliae immunofluorescence test]. Wigand R; Gottschalk R; Falkenbach A; Matthias T; Kaltwasser JP; Hoelzer D Z Rheumatol; 1997; 56(2):53-62. PubMed ID: 9235810 [TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique. Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689 [TBL] [Abstract][Full Text] [Related]
7. Dissociation studies of DNA/anti-DNA complexes in relation to anti-DNA avidity. Smeenk RJ; Van Rooijen A; Swaak TJ J Immunol Methods; 1988 Apr; 109(1):27-35. PubMed ID: 3282012 [TBL] [Abstract][Full Text] [Related]
8. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. ter Borg EJ; Horst G; Hummel EJ; Limburg PC; Kallenberg CG Arthritis Rheum; 1990 May; 33(5):634-43. PubMed ID: 2346519 [TBL] [Abstract][Full Text] [Related]
9. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay]. Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861 [TBL] [Abstract][Full Text] [Related]
10. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Swaak T; Smeenk R Ann Rheum Dis; 1985 Apr; 44(4):245-51. PubMed ID: 3872637 [TBL] [Abstract][Full Text] [Related]
11. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D; Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169 [TBL] [Abstract][Full Text] [Related]
12. Low avidity antibodies to dsDNA as a diagnostic tool. Nossent JC; Huysen V; Smeenk RJ; Swaak AJ Ann Rheum Dis; 1989 Sep; 48(9):748-52. PubMed ID: 2802796 [TBL] [Abstract][Full Text] [Related]
13. Detection of anti-dsDNA as diagnostic tool. Swaak AJ; Groenwold J; Aarden LA; Feltkamp TE Ann Rheum Dis; 1981 Feb; 40(1):45-9. PubMed ID: 7008712 [TBL] [Abstract][Full Text] [Related]
14. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance. Nossent JC; Huysen V; Smeenk RJ; Swaak AJ Ann Rheum Dis; 1989 Aug; 48(8):677-82. PubMed ID: 2789501 [TBL] [Abstract][Full Text] [Related]
15. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456 [TBL] [Abstract][Full Text] [Related]
16. The significance of discrepant Farr and Crithidia luciliae tests. McGuigan L; Edmonds J; Wellings G; Jones M J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050 [TBL] [Abstract][Full Text] [Related]
18. Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay. Smeenk R; van der Lelij G; Aarden L Clin Exp Immunol; 1982 Sep; 49(3):603-10. PubMed ID: 6756723 [TBL] [Abstract][Full Text] [Related]
19. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Riboldi P; Gerosa M; Moroni G; Radice A; Allegri F; Sinico A; Tincani A; Meroni PL Autoimmunity; 2005 Feb; 38(1):39-45. PubMed ID: 15804704 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Kim KH; Han JY; Kim JM; Lee SW; Chung WT Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]